Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

A new compound shows promise as a topical treatment for hair loss.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Cholesterol- and phospholipid-free niosomes improve deep skin drug delivery.

Minoxidil sulfate and pinacidil promote hair growth likely by increasing blood flow, not by activating K channels.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Neurosteroids and benzodiazepines reduce neuron excitability, with lasting effects on inhibitory neurons.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Improved CRBN ligands make protein degraders more effective and drug-like.

Liver enzyme helps minoxidil work better for blood vessel relaxation.

Polyamidoamine dendrimers can change the strength and direction of electroosmotic flow through the skin, affecting drug delivery.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

New drug uses show promise but need more research.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

Different sPLA2 enzymes have unique roles in phospholipid metabolism and biological processes.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

SARMs work differently in tissues due to unique interactions and structures.

A new compound effectively inhibits human 5α-reductase 1.